Biodegradable Scaffold Market is Anticipated to Witness High Growth Owing to Growing Prevalence of Cardiovascular Diseases
![]() |
| Biodegradable Scaffold Market |
Biodegradable scaffolds are used in several medical
applications such as cardiovascular, orthopedic, and neurology. Cardiovascular
diseases such as cardiac failure are on the rise due to increased risk factors
like diabetes, obesity, and smoking. Thus, the demand for biodegradable
scaffolds to treat cardiovascular diseases is rising, driving the market
growth.
Biodegradable scaffolds can be used as a replacement or temporary support for
damaged tissues and organs in the body. They provide structural and mechanical
support to the tissues and facilitate cellular colonization. These scaffolds
degrade gradually as the body replaces them with native tissues. They offer
advantages like biocompatibility, reduced risk of infection, and avoidance of
secondary surgical procedures to remove non-biodegradable implants. With the
growing prevalence of chronic diseases, there is an increasing need for
biodegradable implants that provide tissue regeneration without requiring additional
removal surgeries.
The global biodegradable scaffold market is estimated to be
valued at US$ 2.31 Mn in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Biodegradable
Scaffold Market Size are Medtronic Plc, Koninklijke Philips N.V.,
Abbott, Johnson & Johnson Service Inc., Merit Medical Systems, Inc.,
Stryker, Penumbra, Inc., Acandis GmbH & Co. KG, MicroPort Scientific
Corporation, Terumo Corporation, Cerus Endovascular Limited., ASAHI INTECC USA,
INC., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., iVascular, LifeHealthcare,
Veiva, and Nordson MEDICAL. These players are focusing on new product launches
and mergers & acquisitions to strengthen their presence in the market.
There is high potential for biodegradable scaffolds in applications like
neurological tissue regeneration, orthopedic reconstruction, and wound healing.
With ongoing research, these scaffolds can be developed further to mimic
natural extracellular matrices and promote tissue regeneration more
effectively.
The global biodegradable scaffold market players are expanding their presence
across regions. Manufacturers are focusing on emerging economies in Asia
Pacific and Latin America owing to improved healthcare infrastructure and
rising medical tourism in these regions. Counties like India, China, Brazil
offer high growth potential for biodegradable scaffold products.
Market Drivers
Rising geriatric population susceptible to chronic diseases: The global
geriatric population, aged 65 years or more, is rising rapidly. Older adults
are at a higher risk of developing cardiovascular diseases, neurological
disorders, and orthopedic conditions. This is expected to increase the demand
for biodegradable scaffolds for treatment of age-related diseases.
Technological advancements: Continuous research is underway to develop advanced
biodegradable scaffolds with improved properties like tissue-specific
degradation, enhanced cellular interactions, and integration with host tissues.
New technologies like 3D printing and nanotechnology are helping manufacture
complex scaffold structures mimicking natural extracellular matrices. This is
anticipated to drive the market during the forecast period.
Market Restrains
High costs associated with scaffold development: Manufacturing
biodegradable scaffolds involves expensive processes like material processing,
sterilization, and clinical testing. Developing scaffolds tailored for specific
tissue regeneration further increases costs. This makes biodegradable implants
less affordable for common patients in price-sensitive markets.
Lack of specialized medical professionals: Complex scaffold fabrication
techniques and their usage in tissue engineering procedures require extensive
technical know-how. There is a shortage of specialized medical professionals
trained in regenerative therapies using biodegradable scaffolds. This shortage
acts as a market barrier in their widespread clinical adoption.
Segment Analysis
The biodegradable scaffold market is dominated by synthetic biodegradable
scaffolds sub-segment due to advantages over natural biodegradable scaffolds.
Synthetic biodegradable scaffolds have precise controllable degradation rate as
per the healing of tissues which makes them suitable for various tissue
engineering applications. They also have higher mechanical strength and lower
chances of immunogenicity compared to natural biodegradable scaffolds.
Global Analysis
North America region holds the leading share in the global biodegradable
scaffold market owing to rising prevalence of cardiovascular diseases, growing
demand for minimally invasive surgeries, and presence of major players in the
region. Asia Pacific region is projected to witness the highest growth during
the forecast period due to increasing healthcare expenditure, growing aging
population, rising incidences of chronic diseases. Additionally, improving
healthcare infrastructure and growing medical tourism industry in Asia Pacific
countries are also expected to boost the regional market growth.
Get more insights on Biodegradable
Scaffold Market

Comments
Post a Comment